Related Experiment Videos
[Vascular adhesion protein-1: an unusual adhesion molecule]
Aneta Madej1, Adam Reich, Jacek Szepietowski
1Katedra i Klinika Dermatologii, Wenerologii i Alergologii Akademii Medycznej, Wrocław.
Postepy Higieny I Medycyny Doswiadczalnej (Online)
|June 2, 2005
Summary
Vascular adhesion protein-1 (VAP-1) is a unique molecule involved in lymphocyte migration during inflammation. Its dual role as an adhesion molecule and enzyme impacts various diseases and graft rejection.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Context:
- Lymphocyte migration from blood vessels to tissues is crucial for immune responses to inflammation.
- This migration relies on interactions between endothelial adhesion molecules and lymphocyte ligands.
- The discovery of vascular adhesion protein-1 (VAP-1) stemmed from studies on inflamed synovium in the late 1980s.
Purpose:
- To review current knowledge on the significance of VAP-1.
- To highlight VAP-1's dual function as an adhesion molecule and an enzyme.
- To discuss VAP-1's role in the pathogenesis of various diseases and graft rejection.
Summary:
- Vascular adhesion protein-1 (VAP-1) is an adhesion molecule facilitating T-lymphocyte binding to endothelium.
- VAP-1 also functions as an enzyme catalyzing oxidative deamination, with in vitro studies confirming this dual activity.
- This molecule is implicated in the pathogenesis of inflammatory conditions such as inflammatory bowel disease, liver diseases, and skin diseases, as well as certain neoplasms and graft rejection.
Impact:
- Understanding VAP-1's function provides insights into inflammatory disease mechanisms.
- VAP-1 represents a potential therapeutic target for inflammatory and immune-related disorders.
- Further research into VAP-1's enzymatic and adhesive properties may reveal new treatment strategies.